Contact

feel free to contact us and we will
get back to you as soon as we can.
  • Head Office
  • Gwanggyo R&D Center
  • USA Office

(34141) BVC #121, 125 Gwahak-ro, Yuseong-
gu, Daejeon, Repulic of Korea

Google map

  • TEL + 82-70-8723-0566
  • FAX + 82-70-7966-0567

info@ztibio.com

(16229) 2F GyeongGi-do Business & Science Accelerator, 107 GwangGyo-ro, YeongTong-gu, SuWon-ci, GyeongGi-do, Republic of Korea

Google map

  • TEL + 82-31-213-0566
  • FAX + 82-31-213-0567

info@ztibio.com

9550 Zionsville Rd Suite 1, Indianapolis, IN 46268, United States

Google map

info@ztibio.com

Standard Radiopharmaceuticals
for Theragnostic Oncology

About us

About us

Zero To 1(one), ZTI stands for developing new technologies that were never before.

ZTI BIOSCIENCES, combining its very own original platform nanotechnology with biotech, is developing a next generation therapeutic radiopharmaceuticals for intractable & recurring solid cancers. ZTI, with the Nano Platform tech TERACARRIERTM, will bring a new paradigm of cancer care, unearthing the full potential of radioisotopes, standardizing radiopharmaceuticals, and providing innovative solutions for various indications in the area of intractable oncology.

Business Model

Business Model

History

2023

  1. Super Gap Innovation Start up support program election(KISED)
  2. Series A Investment complete
  3. US Branch Established in Indianapolis
  4. US CDMO production of Drugs for non-Clinical/Clinical research
  5. US GLP Conducting non-clinical trial consigned research

2022

  1. US Tech Transfer to CDMO Completed
  2. 2nd R&D Center Expansion (GBSA)
  3. Bio-Startup Support project election
  4. IP-Narae support project election (KIPA)
  5. Global corp. collaboration program election (MSMES)
  6. K-Camp Final Round Gold Award (KSD)
  7. IP-R&D Strategic support project election(KPSDI)
  8. 2022 Global Jump 300 Program election (KOTRA)

2021

  1. Market-connected Future New-Drug Tech Dev project election(KRIBB)
  2. Bundang SNU Hospital Research Agreement
  3. Harvard Medical Center Research Agreement
  4. U-CONNECT 2021 FINAL Awarded the Grand Prize (Korea Credit Guarantee Fund)

2020

  1. Establishment
  2. First R&D Center Establishment & Certification
  3. Seed Investment
  4. Venture Business Certification (Tech Guarantee)
  5. Network-type Tech Dev Project Elected (Ministry of SBA)
  6. TIPS Project election (Ministry of SBA)

Partners Our Team History